基于聚合物的化疗免疫疗法:结合免疫细胞死亡诱导和PD-L1阻断可增强黑色素瘤的抗瘤免疫力
Jiahui Li1, Hasan Al Faruque1, Emilio Cortes-Sanchez2
1Center for Controlled Chemical Delivery, University of Utah, Salt Lake City, UT 84112, USA; Department of Molecular Pharmaceutics, University of Utah, Salt Lake City, UT 84112, USA.
概括
这项研究介绍了一种基于聚合物的新型化疗免疫疗法,该疗法结合了N- 2- 基) 甲基胺 (HPMA) kopolimer- epirubicin (KT- 1) 和PD- L1 抗剂 (MPPA) 来治疗黑色素瘤. 与传统的免疫检查点抑制剂相比,组合治疗显示出更高的疗效和安全性.
科学领域:
- 癌症学
- 免疫学
- 聚合物化学
背景情况:
- 尽管免疫检查点抑制剂 (ICI) 单一治疗的进展,但黑色素瘤的治疗仍然具有挑战性.
- 需要新的治疗策略来克服当前治疗的局限性,特别是在免疫排除的瘤中.
研究的目的:
- 研究一种基于聚合物的化疗免疫疗法,该疗法结合了N- 2-基) 甲胺 (HPMA) 合聚合物- 皮素结合物 (KT-1) 和PD- L1抗剂 (MPPA).
- 在临床前黑色素瘤模型中评估这种组合策略的有效性和安全性.
主要方法:
- 使用可降解的HPMA共聚物-皮素结合物 (KT-1) 诱导免疫细胞死亡 (ICD).
- 使用多价值HPMA共聚物- 抗剂的PD- L1 (MPPA) 来阻止PD- L1相互作用.
- 用单细胞RNA测序和耗尽研究对B16F10黑色素瘤模型进行组合治疗并评估免疫反应.
- 在NOD小鼠中评估安全性,以评估潜在的自身免疫不良影响.
主要成果:
- 一个为期3天的KT-1+MPPA剂量计划比一个为期7天的计划更有效.
- 通过KT-1单一治疗增强了CD8+T细胞介导的免疫力.
- 组合疗法 (KT- 1 + MPPA) 显示出优于连续剂量的疗效.
- 单细胞RNA测序显示,结合疗法增强了树突细胞成熟,CD8+ T细胞激活,降低了调控性T细胞活性.
- 与传统的抗PD- L1抗体不同,MPPA没有表现出自身免疫性不良反应.
结论:
- 基于HPMA共聚物的化疗免疫疗法是传统ICI疗法的有希望和更安全的替代方案.
- 这种策略有效地克服了瘤中的免疫排斥,并增强了抗瘤免疫力.
- 结合ICD诱导化学疗法和PD-L1阻断为黑色素瘤提供了一种有效的治疗方法.
相关概念视频
Tumor Immunotherapy
658
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
658
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Cancer Vaccines
509
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
509
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K


